01.12.2021 SynBiotic SE  DE000A3E5A59

DGAP-News: SynBiotic SE: Most important cannabis merger in Europe


 

DGAP-News: SynBiotic SE / Key word(s): Takeover
SynBiotic SE: Most important cannabis merger in Europe

01.12.2021 / 14:54
The issuer is solely responsible for the content of this announcement.



SynBiotic SE: Most important cannabis merger in Europe

- SynBiotic SE acquires 50.1% of Daniel Kruse's group of companies at a valuation of EUR 11.2 million

- Hanf Farm GmbH, Hempro International GmbH, Hemp Factory GmbH and MH medical hemp GmbH join the German cannabis group

- EIHA President Daniel Kruse and industry pioneer Rafael Dulon bring a combined half a century of cannabis expertise to SynBiotic SE

- SynBiotic SE raises sales forecast for 2021 to EUR 15 million (pro forma consolidated)

Munich, November 30, 2021.
It is the most significant merger in the European cannabis sector. SynBiotic SE has acquired 50.1% of Daniel Kruse's group of companies, with four leading companies in their fields, at a valuation of EUR 11.2 million, thereby securing the subsequent acquisition of the remaining 49.9% by option. The listed cannabis group is hence raising its sales forecast for 2021 to EUR 15 million.

With Daniel Kruse's four companies, Hanf Farm GmbH, Hempro International GmbH, Hemp Factory GmbH and MH medical hemp GmbH, SynBiotic SE's portfolio is being enriched by important infrastructures and profitable brands. Lars Müller, CEO of SynBiotic SE: "The cooperation with Daniel Kruse is a genuine accolade in the cannabis sector. SynBiotic SE will benefit massively from what amounts to over half a century of combined know-how gathered by industry pioneers Daniel Kruse and Rafael Dulon. So far, the only comparable acquisitions have taken place in Canada. This makes this merger the most significant in the European cannabis sector. I am greatly honored by the trust Daniel Kruse and Rafael Dulon have displayed in SynBiotic SE; this shows that we are on the right track with our vision."

Daniel Kruse has been an entrepreneur in the hemp food industry for over 25 years, with a focus on cannabinoids such as CBD. He is also President of the European Industrial Hemp Association (EIHA). His cooperation with international experts as well as with the advisory committee of the EIHA combines his well-founded know-how from practice and science in the hemp and food industry. Kruse advocates on behalf of hemp industry stakeholders before the European Union and the German government. With his work, he has made a significant contribution to advancing the legal and regulatory framework for the hemp industry.

Daniel Kruse, industry pioneer, entrepreneur and President of the European Industrial Hemp Association (EIHA), commented on the merger: "After 25 years in the hemp industry, it is a great pleasure and honor for me to have found the right partner for the coming decades with SynBiotic SE. Our decades of experience alongside the supply chain of our group of companies find an excellent complement in the enormous dynamics of SynBiotic SE. The appealing nature and charisma of Lars Müller and his team contribute, but it is above all their displaying the highest professionalism and efficiency that has won us over. This combination makes SynBiotic SE the next Unicorn candidate and an ideal partner for me. The European hemp and cannabis market is set to become one of the most exciting and successful industries in the coming years. The challenges yet to be mastered are well known, but the resulting opportunities are unlimited."

Rafael Dulon has also been working in the hemp industry for some 25 years. In 2015, he was awarded the Global Hemp Innovation Award at the World Hemp Congress for the development of a hemp harvester. Dulon's expertise can be seen in the cultivation, harvesting and further processing of industrial hemp in organic quality. Rafael Dulon, Managing Director of Hanf Farm GmbH and expert member of the International Institute for Cannabinoids (ICANNA) commented on the merger: "The synergies created for Hanf Farm through its inclusion in the SynBiotic SE Group will lead to significantly faster growth. Within SynBiotic SE's strong network of people and companies, we will be much better able to implement our ambitious goals in expanding our capacities and competencies as an original agricultural producer and primary processor of hemp. I am very pleased that Lars Müller fully supports my ideas for the development of sustainable, organic agriculture. Together, we will use the great potential of hemp in agriculture and market our healthy, climate-friendly products even more vigorously, and as well develop many new products. I look forward to using my many years of experience to help support Lars Müller's vision."

An overview of the companies in Daniel Kruse's group:

- Hanf Farm GmbH: The largest organic hemp farm in Europe

- Hempro International GmbH: The largest hemp food distribution in Central Europe, with an international supplier and customer network and profitable own brands

- Hemp Factory GmbH: The largest hemp food production in Central Europe

- MH medical hemp GmbH: CBD expert and wholesaler with THC BtM approval
 

About SynBiotic SE
SynBiotic SE is the largest listed group in Europe in the hemp and cannabis sector and pursues an EU-focused buy & build investment strategy. The group of companies covers the entire supply chain from cultivation to production to retail - from field to shelf. One of the company's core businesses is the research & development, production and marketing of cannabinoid- and terpene-based solutions to major societal problems such as pain, sleep and anxiety. In doing so, SynBiotic SE is active not only in the dietary supplement and cosmetics markets, but also in the medical and, in the future, recreational cannabis sector.



01.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SynBiotic SE
Barer Str. 7
80333 München
Germany
E-mail: [email protected]
Internet: https://www.synbiotic.com/
ISIN: DE000A3E5A59
WKN: A3E5A5
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Tradegate Exchange
EQS News ID: 1253421

 
End of News DGAP News Service

1253421  01.12.2021 

fncls.ssp?fn=show_t_gif&application_id=1253421&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 5,45 15,00 0,00
EBITDA1,2 0,00 0,00 0,00 -0,01 -0,71 -0,85 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 -13,03 -5,67 0,00
EBIT1,4 0,00 0,00 0,00 -0,01 -0,83 -1,45 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 -15,23 -9,67 0,00
Jahresüberschuss1 0,00 0,00 0,00 -0,01 -0,88 -1,80 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 -16,15 -12,00 0,00
Cashflow1,7 0,00 0,00 0,00 -0,01 -1,26 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 -0,15 -2,50 -0,60
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
SynBiotic
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A3E5A5 13,600 - 56,91
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 -123,64
KBV KCV KUV EV/EBITDA
1,32 - 10,45 -80,21
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 05.08.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.09.2021 30.06.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-17,44% -34,96% -53,42% -31,17%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SynBiotic SE  ISIN: DE000A3E5A59 können Sie bei DGAP abrufen


Beteiligungen , A3E5A5 , SBX , XETR:SBX